Publication Year

Teeguarden JG, Waechter JM Jr, Clewell HJ 3rd, Covington TR, Barton HA. 2005. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding and uterine tissue dose metrics of bisphenol A: A physiologically based pharmacokinetic approach. Toxicol Sci 85:429–446.

Staskal DF, Diliberto JJ, DeVito MJ, Birnbaum LS. 2005. Inhibition of human and rat CYP1A2 by TCDD and dioxin-like chemicals. Toxicol Sci 84(2):225-31; doi: 10.1093/toxsci/kfi090.

Staskal DF, Diliberto JJ, DeVito MJ, Birnbaum LS. 2005. Toxicokinetics of BDE 47 in female mice: Effects of dose, route of exposure, and time. Toxicol Sci. 83(2):215-23; doi: 10.1093/toxsci/kfi018.

Urban JD, Mailman RB. Characterization of the N27 dopaminergic cell line as a model for elucidating the actions of functionally selective dopaminergic ligands. 35th Annual Neuroscience Meeting, Washington, DC, November 2005.

Grasty RC, Roberts N, Klinefelter G, Bjork JA, Wallace KB, Lau CS, Rogers JM. 2005. Effects of prenatal perfluorooctanesulfonate (PFOS) exposure on lung maturation in the perinatal rat. Birth Defects Res A 73: 314.